Jade Biosciences, Inc. (JBIO)
Healthcare
Biotechnology
19.80 $
-1.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Jade Biosciences, Inc. (JBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -95 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -7.9 | -27 | -39 | -57 | -71 | -95 | |
| 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.0 | |
| – | – | – | – | 0.0 | 20 | |
| 1.0 | -6.5 | 7.8 | 9.8 | -11 | -8.2 | |
| 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | |
| – | -113 | 6.9 | 12 | 56 | -247 | |
| – | – | – | – | – | 0.0 | |
| 8.9 | 190 | 0.4 | 46 | 25 | 361 | |
| 1.1 | 50 | -32 | 1.1 | 10 | 55 | |
| -7.9 | -28 | -39 | -57 | -71 | -95 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.